Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.195 USD | -8.90% | -7.72% | +10.09% |
05-09 | Stifel Adjusts Price Target on C4 Therapeutics to $14 From $13, Maintains Buy Rating | MT |
05-08 | C4 Therapeutics Shares Decline as Q1 Revenue Misses Estimates | MT |
- Stock Market
- Equities
- CCCC Stock
- News C4 Therapeutics, Inc.
- MarketScreener Editorial Features